Literature DB >> 29542306

CAR T-Cell Therapy in Large B-Cell Lymphoma.

Alfonso Quintás-Cardama1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29542306     DOI： 10.1056/NEJMc1800913

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

Review 1.  Adipocyte and lipid metabolism in cancer drug resistance.

Authors:  Yihai Cao
Journal:  J Clin Invest       Date:  2019-07-02       Impact factor: 14.808

2.  Significantly increased anti-tumor activity of carcinoembryonic antigen-specific chimeric antigen receptor T cells in combination with recombinant human IL-12.

Authors:  Xiaowei Chi; Peiwei Yang; Erhao Zhang; Jieyi Gu; Hui Xu; Mengwei Li; Xinmei Gao; Xin Li; Yinan Zhang; Hanmei Xu; Jialiang Hu
Journal:  Cancer Med       Date:  2019-06-25       Impact factor: 4.452

3.  Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies.

Authors:  Xin-An Lu; Yuqin Song; Jun Zhu; Zhitao Ying; Ting He; Xiaopei Wang; Wen Zheng; Ningjing Lin; Meifeng Tu; Yan Xie; Lingyan Ping; Chen Zhang; Weiping Liu; Lijuan Deng; Meng Wu; Feier Feng; Xin Leng; Tingting Du; Feifei Qi; Xuelian Hu; Yanping Ding
Journal:  BMC Cancer       Date:  2021-02-25       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.